Literature DB >> 14443930

Progression and prognosis in Parkinson's disease.

R S SCHWAB.   

Abstract

Entities:  

Keywords:  PARALYSIS AGITANS

Mesh：

Year:  1960        PMID： 14443930     DOI： 10.1097/00005053-196006000-00017

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN： 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  9 in total

1.  [Experiences with stereotactic surgery. IV. Onthe long-term effect of bilateral pallidotomy in Parkinson's syndrome].

Authors:  H ORTHNER; F ROEDER
Journal:  Acta Neurochir (Wien)       Date:  1962-12-12       Impact factor: 2.216

2.  Residual sympathetic tone is associated with reduced insulin sensitivity in patients with autonomic failure.

Authors:  Jorge E Celedonio; Amy C Arnold; William D Dupont; Claudia E Ramirez; André Diedrich; Luis E Okamoto; Satish R Raj; David Robertson; Amanda C Peltier; Italo Biaggioni; Cyndya A Shibao
Journal:  Clin Auton Res       Date:  2015-09-10       Impact factor: 4.435

Review 3.  Assessment of extrapyramidal disorders.

Authors:  C D Marsden; M Schachter
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

4.  Mortality of patients with Parkinson's disease treated with levodopa.

Authors:  R J Marttila; U K Rinne; T Siirtola; V Sonninen
Journal:  J Neurol       Date:  1977-10-07       Impact factor: 4.849

Review 5.  Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.

Authors:  Valeria Calsolaro; Paul Edison
Journal:  CNS Drugs       Date:  2015-12       Impact factor: 5.749

Review 6.  Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.

Authors:  Susana Cardoso; Renato Santos; Sonia Correia; Cristina Carvalho; Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Mark A Smith; George Perry; Paula I Moreira
Journal:  Pharmaceuticals (Basel)       Date:  2009-12-23

Review 7.  Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson's Disease.

Authors:  Paula A Q Videira; Margarida Castro-Caldas
Journal:  Front Neurosci       Date:  2018-06-07       Impact factor: 4.677

8.  Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.

Authors:  Domenico Sergi; Justine Renaud; Nicola Simola; Maria-Grazia Martinoli
Journal:  Front Aging Neurosci       Date:  2019-11-08       Impact factor: 5.750

Review 9.  Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease-Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors.

Authors:  Kai-Jung Lin; Tzu-Jou Wang; Shang-Der Chen; Kai-Lieh Lin; Chia-Wei Liou; Min-Yu Lan; Yao-Chung Chuang; Jiin-Haur Chuang; Pei-Wen Wang; Jong-Jer Lee; Feng-Sheng Wang; Hung-Yu Lin; Tsu-Kung Lin
Journal:  Antioxidants (Basel)       Date:  2021-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.